KLK3 and pachyonychia congenita: Even at low PSA levels under 0.2 ng/ml, the PR was 41%, which shows that 68Ga-PSMA-11 PET/CT can detect PC recurrence early, therefore enabling individualized therapeutic decision-making and risk adapted treatment as well as selecting suitable patients for radionuclide therapy with 177Lutetium-PSMA.